Increased exercise and nutritional diets have been the core of any weight loss program. Surgical procedures such as gastric bypass, and LAP-Band are used to reduce the size of the stomach so you eat less-an invasive process to lose weight. Wouldn’t it be nice if there was an easier way?
Surgery and diets has not stopped scientist from developing mechanical ways one can shed pounds. Allurion Technologies is developing a medical device to make treating obesity easier to swallow — a pill that delivers a high-tech balloon that E X P A N D S in your stomach to make you feel full. There are various nutritional products on the market that claim “gastric bypass results” (Roca Labs) but a long-term solution from a “device?” I am more than intrigued with how?
The material can expand 200 to 300 times its size, though Allurion’s won’t hit that size. When the treatment is done, the material would be dissolved via an oral solution. So long it doesn’t require a trip to the bathroom, I want to know more.
Recently highlighted by the Boston Herald, the company’s medical device consists of a hydrogel-based material delivered to the stomach in a pill form. “We take the endoscopic procedure out of the equation,” Allurion CEO Jonathan Wecker told the Herald. “We have a medical device that fits in a pill and expands in the stomach over several months.” Allurion’s medical device expands in the stomach and presses against its walls, making the patient feel full. Once the treatment is complete, the patient takes an oral solution that dissolves the “balloon.”
Allurion is taking the same approach as ReShape Medical, another device offering a nonsurgical, non drug obesity treatment. It entails the insertion of an endoscope through the mouth and into the stomach, where an uninflated balloon is positioned in the stomach via a guidewire than inflated with saline. The device remains in the stomach for six months as a form of portion control. Just like the Allurion pill, it dose not change the anatomy of the stomach; it simply occupies space to reduce the capacity for food. The device is removed through the mouth with an endoscope at the end of six months.
According to the Centers for Disease Control and Prevention, approximately one-third of U.S. adults are obese. Even though the statistic doesn’t bode well for the health of America, it does represent an opportunity for medical device manufactures. Allurion, ReShape Medical and other innovative companies are tackling an area with a great deal of market potential. These devices that offer a nonsurgical, nondrug approach to weight loss could revolutionize the field of obesity devices if they make it to market. Gaining profits while helping patients shed pounds sounds like a potentially lucrative concept